Imatinib Mesylate CAS No.220127-57-1 Pharmaceutical raw materials
Product detail
Imatinib mesylate, also known as Gleevec, is a targeted therapy used to treat certain types of cancer, including chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST). Our company is a leading manufacturer and supplier of Imatinib Mesylate, offering premium quality products with excellent physical and chemical properties.
product detail
|
Product name |
Imatinib Mesylate |
|
CAS No. |
220127-57-1 |
|
EINECS |
606-892-3 |
|
Formula |
C30h35n7o4s |
|
Molecular Weight |
589.715 |
|
Appearance |
White Powder |
|
Purity |
≥98% |
|
Type |
Pharmaceutical raw materials |
Our imatinib mesylate products feature high purity, stability and solubility, making them ideal for pharmaceutical formulations. Through precise control of the manufacturing process, we ensure that our products meet the most stringent quality standards, delivering consistent performance and efficacy in pharmaceutical applications.
- High purity, high quality, in compliance with pharmacopoeia standards
- Excellent stability and solubility, ensuring formulation flexibility
- Produced in state-of-the-art facilities with strict quality control measures
- Reliable and stable supply to meet the needs of the pharmaceutical industry
- Integrated production and trading to ensure cost-effective pricing
- Strong R&D capabilities and continuous product improvement
- Flexible packaging and customization options to meet specific customer needs
- Efficient logistics and distribution network, timely delivery
Imatinib mesylate is a key ingredient in the production of life-saving drugs used in cancer treatment. Our products play a critical role in helping pharmaceutical companies formulate high-quality medicines that improve patient outcomes. Our commitment to quality and reliability has made us a trusted partner to the pharmaceutical industry.
In conclusion, our imatinib mesylate stands out as a top pharmaceutical ingredient, offering superior physical and chemical properties and meeting the stringent requirements of the industry. With our combined manufacturing and trading capabilities, we are committed to providing reliable and high-quality products to support the development of life-saving medicines.